The investigation has confirmed that lower than expected vitros ft4 results were obtained from a patient sample correlation performed between two vitros users using a vitros immunodiagnostic products ft4 reagent lot 4060 on a vitros 5600 integrated system.A definitive assignable cause for the lower than expected vitros ft4 results could not be determined.Based on historical quality control results, a vitros ft4 lot 4060 performance issue is not a likely contributor to the event.Additionally, there is also no indication of an instrument malfunction and unexpected instrument performance is not a likely contributor to the event as precision testing performed on the instrument was within ortho guidelines.Furthermore, pre-analytical sample processing could not be ruled out as a contributing factor, as it was established that the customer was not following the sample collection device manufacture¿s recommendation for sample centrifugation.It is possible that cellular debris, due to poor sample preparation, was present in the affected samples, although this could not be confirmed.The assignable cause is unknown.
|
A customer reported lower than expected vitros ft4 results obtained from a patient sample correlation performed between two vitros users using a vitros immunodiagnostic products ft4 reagent lot 4060 on a vitros 5600 integrated system.Patient sample 3 result of 1.95 ng/dl vs.The expected result of 2.57 ng/dl.Patient sample 10 result of 1.77 ng/dl vs.The expected result of 2.30 ng/dl.Biased results of the direction and magnitude observed may lead to inappropriate physician action.The vitros ft4 results were reported from the customer¿s laboratory.However, no treatment was altered, initiated or stopped based on the reported results and ortho has not been made aware of any allegation of patient harm as a result of this event.(b)(4).
|